Modulation of Wnt/β-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer
Open Access
- 13 June 2011
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 31 (2), 213-225
- https://doi.org/10.1038/onc.2011.228
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- WLS-dependent secretion of WNT3A requires Ser209 acylation and vacuolar acidificationJournal of Cell Science, 2010
- DNA Demethylase Activity Maintains Intestinal Cells in an Undifferentiated State Following Loss of APCCell, 2010
- Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosisProceedings of the National Academy of Sciences of the United States of America, 2010
- A Re-evaluation of the “Oncogenic” Nature of Wnt/β-catenin Signaling in Melanoma and Other CancersCurrent Oncology Reports, 2010
- The antitumor activity of the fungicide ciclopiroxInternational Journal of Cancer, 2010
- Carteriosulfonic Acids A−C, GSK-3β Inhibitors from a Carteriospongia sp.Journal of Natural Products, 2009
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1Science, 2009
- A Two-Step Model for Colon Adenoma Initiation and Progression Caused by APC LossCell, 2009
- Psammaplin A as a general activator of cell-based signaling assays via HDAC inhibition and studies on some bromotyrosine derivativesBioorganic & Medicinal Chemistry, 2009
- Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumorsGenome Biology, 2007